FOXC1 Regulation of miR-31-5p Confers Oxaliplatin Resistance by Targeting LATS2 in Colorectal Cancer

Colorectal cancer (CRC) is the second leading cause of cancer-related illness worldwide and one of the most common malignancies. Therefore, colorectal cancer research and cases have gained increasing attention. Oxaliplatin (OXA) is currently used in first-line chemotherapy to treat stage III and sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Hsi-Hsien, Kuo, Wei-Wen, Shih, Hui-Nung, Cheng, Sue-Fei, Yang, Ching-Kuo, Chen, Ming-Cheng, Tu, Chuan-Chou, Viswanadha, Vijaya Padma, Liao, Po-Hsiang, Huang, Chih-Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827018/
https://www.ncbi.nlm.nih.gov/pubmed/31623173
http://dx.doi.org/10.3390/cancers11101576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6827018/
https://www.ncbi.nlm.nih.gov/pubmed/31623173
http://dx.doi.org/10.3390/cancers11101576

Ejemplares similares